Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model
Background: 5-Fluorouracil (5-FU) is a widely used chemotherapeutic drug in clinical cancer treatment, including hepatocellular carcinoma (HCC). A correct understanding of the mechanisms leading to a low or lack of sensitivity of HCC to 5-FU-based treatment is a key element in the current personaliz...
Saved in:
Main Authors: | Xinyu Gu (Author), Shuang Li (Author), Xiao Ma (Author), Di Huang (Author), Penghui Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway
by: Xuejing Zou, et al.
Published: (2016) -
Identification of a prognostic evaluator from glutamine metabolic heterogeneity studies within and between tissues in hepatocellular carcinoma
by: Jie Bao, et al.
Published: (2023) -
CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma
by: Hao Ding, et al.
Published: (2020) -
L-arginine combination with 5-fluorouracil inhibit hepatocellular carcinoma cells through suppressing iNOS/NO/AKT-mediated glycolysis
by: Yile Hu, et al.
Published: (2024) -
OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma
by: Yang An, et al.
Published: (2020)